CUSIP: 75525N107
Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
54,753,282
-
Share change
-
+466,346
-
Total reported value
-
$3,402,052,410
-
Price per share
-
$62.17
-
Number of holders
-
106
-
Value change
-
+$118,582,799
-
Number of buys
-
74
-
Number of sells
-
38
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2024
-
Previous quarter:
Q3 2023
Recent filing periods for CUSIP 75525N107:
Institutional Holders of RAYZEBIO INC - COM (RYZB) as of Q4 2023
As of 31 Dec 2023,
RAYZEBIO INC - COM (RYZB) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,753,282 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, venBio Partners LLC, Versant Venture Management, LLC, VR Adviser, LLC, WELLINGTON MANAGEMENT GROUP LLP, Sofinnova Investments, Inc., ORBIMED ADVISORS LLC, Redmile Group, LLC, Samsara BioCapital, LLC, and BlackRock Inc..
This page lists
106
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.